## LUCAS WONG

| | Title| Clinical Professor  
---|---  
Institution| Baylor College of Medicine  
Department| Department of Medicine  
Address| 2401 S 31st St  
Temple, TX 76508  
  
Email|
![](https://profiles.viictr.org/profile/modules/CustomViewPersonGeneralInfo/EmailHandler.ashx?msg=Gr4z4HaJF4T7Qa%2fv43aML7CZ&rnd=aaa1de04-77fb-4b65-9f65-08af0c019305)  
vCard| [Download
vCard](https://profiles.viictr.org/profile/modules/CustomViewPersonGeneralInfo/vcard.aspx?subject=41415739)  
  

  
![Collapse](https://profiles.viictr.org/Profile/Modules/PropertyList/images/minusSign.gif)
Bibliographic  

![Collapse](https://profiles.viictr.org/Profile/Modules/PropertyList/images/minusSign.gif)
selected publications

Publications listed below are automatically derived from MEDLINE/PubMed and
other sources, which might result in incorrect or missing publications.
Faculty can
[login](https://profiles.viictr.org/loginOptions.aspx?pin=send&method=login&edit=true)
to make corrections and additions.

Newest | Oldest | Most Cited | Most Discussed | Timeline | Field Summary | Plain Text

PMC Citations indicate the number of times the publication was cited by
articles in PubMed Central, and the Altmetric score represents citations in
news articles and social media. (Note that publications are often cited in
additional ways that are not shown here.) Fields are based on how the National
Library of Medicine (NLM) classifies the publication's journal and might not
represent the specific topic of the publication. Translation tags are based on
the publication type and the MeSH terms NLM assigns to the publication. Some
publications (especially newer ones and publications not in PubMed) might not
yet be assigned Field or Translation tags.) Click a Field or Translation tag
to filter the publications.

  1. Kim R, Tehfe M, Kavan P, Chaves J, Kortmansky JS, Chen EX, Lieu CH, **Wong L** , Fakih M, Spencer K, Zhao Q, Predoiu R, Li C, Leconte P, Adelberg D, Chiorean EG. Pembrolizumab Plus mFOLFOX7 or FOLFIRI for Microsatellite Stable/Mismatch Repair-Proficient Metastatic Colorectal Cancer: KEYNOTE-651 Cohorts B and D. Clin Colorectal Cancer. 2024 Jun; 23(2):118-127.e6. PMID: [38762348](//www.ncbi.nlm.nih.gov/pubmed/38762348).

Citations:  Fields:

Gas GastroenterologyNeo Neoplasms

Translation:HumansCellsCTClinical Trials

  2. Chen EX, Kavan P, Tehfe M, Kortmansky JS, Sawyer MB, Chiorean EG, Lieu CH, Polite B, **Wong L** , Fakih M, Spencer K, Chaves J, Li C, Leconte P, Adelberg D, Kim R. Pembrolizumab Plus Binimetinib With or Without Chemotherapy for MSS/pMMR Metastatic Colorectal Cancer: Outcomes From KEYNOTE-651 Cohorts A, C, and E. Clin Colorectal Cancer. 2024 Jun; 23(2):183-193. PMID: [38653648](//www.ncbi.nlm.nih.gov/pubmed/38653648).

Citations:  Fields:

Gas GastroenterologyNeo Neoplasms

Translation:HumansCellsCTClinical Trials

  3. Hunter JJ, Maunder RG, Sui D, Esplen MJ, Chaoul A, Fisch MJ, Bassett RL, Harden-Harrison MM, Lagrone L, **Wong L** , Baez-Diaz L, [Cohen L](https://profiles.viictr.org/profile/12583322). A randomized trial of nurse-administered behavioral interventions to manage anticipatory nausea and vomiting in chemotherapy. Cancer Med. 2020 03; 9(5):1733-1740. PMID: [31957269](//www.ncbi.nlm.nih.gov/pubmed/31957269); PMCID: [PMC7050098](//www.ncbi.nlm.nih.gov/pmc/articles/PMC7050098).

Citations:
[4](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/31957269/citedby/) Fields:

Neo Neoplasms

Translation:Humans

  4. Cohen SJ, Zalupski MM, Conkling P, Nugent F, Ma WW, Modiano M, Pascual R, Lee FC, **Wong L** , Hersh E. A Phase 2 Randomized, Double-Blind, Multicenter Trial of Imexon Plus Gemcitabine Versus Gemcitabine Plus Placebo in Patients With Metastatic Chemotherapy-na?ve Pancreatic Adenocarcinoma. Am J Clin Oncol. 2018 03; 41(3):230-235. PMID: [26709865](//www.ncbi.nlm.nih.gov/pubmed/26709865).

Citations:

  5. Gerber DE, Swanson P, Lopez-Chavez A, **Wong L** , Dowlati A, Pennell NA, Cronier DM, Qin A, Ilaria R, Cosaert J, Shahir A, Baggstrom MQ. Phase II study of olaratumab with paclitaxel/carboplatin (P/C) or P/C alone in previously untreated advanced NSCLC. Lung Cancer. 2017 09; 111:108-115. PMID: [28838379](//www.ncbi.nlm.nih.gov/pubmed/28838379); PMCID: [PMC5672830](//www.ncbi.nlm.nih.gov/pmc/articles/PMC5672830).

Citations:

  6. Reynolds J, Chamberland-Tremblay A, Herrington JD, Munoz Maldonado Y, **Wong L**. High- versus low-dose leucovorin in the modified FOLFOX6 regimen for first-line treatment of metastatic colorectal cancer. J Oncol Pharm Pract. 2017 Apr; 23(3):173-178. PMID: [26786027](//www.ncbi.nlm.nih.gov/pubmed/26786027).

Citations:

  7. [Kee BK](https://profiles.viictr.org/profile/12583557), Morris JS, Slack RS, Crocenzi T, **Wong L** , Esparaz B, [Overman M](https://profiles.viictr.org/profile/12583817), Glover K, Jones D, Wen S, Fisch MJ. A phase II, randomized, double blind trial of calcium aluminosilicate clay versus placebo for the prevention of diarrhea in patients with metastatic colorectal cancer treated with irinotecan. Support Care Cancer. 2015 Mar; 23(3):661-70. PMID: [25160493](//www.ncbi.nlm.nih.gov/pubmed/25160493).

Citations:
[4](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/25160493/citedby/) Fields:

Neo NeoplasmsPal Palliative Care

Translation:HumansCTClinical Trials

  8. Whitehead RP, Rankin C, Hoff PM, Gold PJ, Billingsley KG, Chapman RA, **Wong L** , Ward JH, Abbruzzese JL, Blanke CD. Phase II trial of romidepsin (NSC-630176) in previously treated colorectal cancer patients with advanced disease: a Southwest Oncology Group study (S0336). Invest New Drugs. 2009 Oct; 27(5):469-75. PMID: [18941712](//www.ncbi.nlm.nih.gov/pubmed/18941712); PMCID: [PMC3024913](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3024913).

Citations:

  9. Hochster HS, Hart LL, Ramanathan RK, Childs BH, Hainsworth JD, Cohn AL, **Wong L** , Fehrenbacher L, Abubakr Y, Saif MW, Schwartzberg L, Hedrick E. Safety and efficacy of oxaliplatin and fluoropyrimidine regimens with or without bevacizumab as first-line treatment of metastatic colorectal cancer: results of the TREE Study. J Clin Oncol. 2008 Jul 20; 26(21):3523-9. PMID: [18640933](//www.ncbi.nlm.nih.gov/pubmed/18640933).

Citations:

This graph shows the total number of publications by year. To see the data as
text, click here.

![Bar chart showing 9 publications over 7 distinct years, with a maximum of 2
publications in 2008 and
2024](//chart.googleapis.com/chart?chs=595x100&chf=bg,s,ffffff|c,s,ffffff&chxt=x,y&chxl=0:|'94||'96||'98||'00||'02||'04||'06||'08||'10||'12||'14||'16||'18||'20||'22||'24|1:|0|2&cht=bvs&chd=t:0,0,0,0,0,0,0,0,0,0,0,0,0,0,100,0,0,0,0,0,50,0,50,50,50,0,50,0,0,0,100&chdl=Publications&chco=80B1D3&chbh=10)

This graph shows the total number of publications by year. To return to the
graph, click here.

Year| Publications  
---|---  
2008| 2  
2014| 1  
2016| 1  
2017| 1  
2018| 1  
2020| 1  
2024| 2  
  
This graph shows the number and percent of publications by field. Fields are
based on how the National Library of Medicine (NLM) classifies the
publications' journals and might not represent the specific topics of the
publications. Note that an individual publication can be assigned to more than
one field. As a result, the publication counts in this graph might add up to
more than the number of publications the person has written. To see the data
as text, click here.

This graph shows the number and percent of publications by field. Fields are
based on how the National Library of Medicine (NLM) classifies the
publications' journals and might not represent the specific topics of the
publications. Note that an individual publication can be assigned to more than
one field. As a result, the publication counts in this graph might add up to
more than the number of publications the person has written. To see the data
as text, click here.

Start with: newest oldest Include: line numbers double spacing all authors
publication IDs

WONG's Networks

Click the

Explore

buttons for more information and interactive visualizations!

Concepts (57)
![](https://profiles.viictr.org/profile/modules/passivelist/Images/info.png)

Derived automatically from this person's publications.

  * [Leucovorin](https://profiles.viictr.org/profile/259969)
  * [Colorectal Neoplasms](https://profiles.viictr.org/profile/253332)
  * [Fluorouracil](https://profiles.viictr.org/profile/257491)
  * [Organoplatinum Compounds](https://profiles.viictr.org/profile/242460)
  * [Antineoplastic Combined Chemotherapy Protocols](https://profiles.viictr.org/profile/242440)

[Explore](https://profiles.viictr.org/profile/41415739/198)

_

Co-Authors (3)
![](https://profiles.viictr.org/profile/modules/passivelist/Images/info.png)

People in Profiles who have published with this person.

  * [COHEN, LORENZO](https://profiles.viictr.org/profile/12583322)
  * [KEE, BRYAN K](https://profiles.viictr.org/profile/12583557)
  * [OVERMAN, MICHAEL JAMES](https://profiles.viictr.org/profile/12583817)

[Explore](https://profiles.viictr.org/profile/41415739/345)

_

Similar People (60)
![](https://profiles.viictr.org/profile/modules/passivelist/Images/info.png)

People who share similar concepts with this person.

  * [KANTARJIAN, HAGOP M](https://profiles.viictr.org/profile/12582901)
  * [VAUTHEY, JEAN NICOLAS](https://profiles.viictr.org/profile/12582959)
  * [AJANI, JAFFER A](https://profiles.viictr.org/profile/12582892)
  * [OVERMAN, MICHAEL JAMES](https://profiles.viictr.org/profile/12583817)
  * [ENG, CATHY](https://profiles.viictr.org/profile/12583785)

[Explore](https://profiles.viictr.org/profile/41415739/476)

_

Same Department [ ![Expand
Description](https://profiles.viictr.org/Framework/Images/info.png)
](JavaScript:toggleVisibility\('sdDescript'\);)

People who are also in this person's primary department.

  * [FAN, JENNIFER](https://profiles.viictr.org/profile/41581723)
  * [HYMAN, BARRY](https://profiles.viictr.org/profile/10282047)
  * [MORGAN, NICHOLAS](https://profiles.viictr.org/profile/41209097)
  * [WALKER, HAYLEY](https://profiles.viictr.org/profile/35194391)
  * [ZHANG, HAL](https://profiles.viictr.org/profile/31362085)

[Explore](https://profiles.viictr.org/search/default.aspx?searchtype=people&searchfor=&SearchRequest=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)

_

